NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
Back to search
Official data from USPTO
DE SIMONE FORMULATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DE SIMONE FORMULATION
ST13
US500000088794812Class
5
Filing
88794812
Registration
6721007
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/24/2022
Trademark type
Word
Nice classes
5
Filing date
02/12/2020
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2016-00-00
First use in commerce
2016-00-00
Drawing code
4
Owner type
16
Owner location
Rockville, MD
Examiner
DEFORD, JEFFREY S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ExeGi Pharma, LLC
Representatives
John W. McGlynn RATNERPRESTIA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Food supplements; Food supplements for treating digestive disorders; Health food supplements; Nutritional supplementsprobiotic compositions; Dietary and nutritional supplements; Live biotherapeutics for the treatment of inflammatory bowel diseasesulcerative colitisirritable bowel syndromepouchitisliver diseases; Medical Fooddietetic foods in the nature of powder specially adapted for medical use; Probiotic supplements; lactic acid bacteria compositions for use as a human drug for treating diseases of the gastro-intestinal tractdiseases of the oral cavity and vaginal diseases; lactic acid bacteria compositions for use as a veterinary drug for treating diseases of the gastro-intestinal tractdiseases of the oral cavity and vaginal diseases; lactic acid bacteria compositions for use as a dietary or food supplement; veterinary supplements; veterinary probiotic supplements
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/22/2022
PUBO
PUBLISHED FOR OPPOSITION
02/22/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/22/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/24/2021
GNFR
FINAL REFUSAL E-MAILED
06/24/2021
CNFR
FINAL REFUSAL WRITTEN
06/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/30/2020
GNRT
NON-FINAL ACTION E-MAILED
11/30/2020
CNRT
NON-FINAL ACTION WRITTEN
11/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/06/2020
GNRT
NON-FINAL ACTION E-MAILED
05/06/2020
CNRT
NON-FINAL ACTION WRITTEN
05/06/2020
DOCK
ASSIGNED TO EXAMINER
04/30/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2020
NWAP
NEW APPLICATION ENTERED
02/15/2020
Continuous trademark protection
Get notified about every new filing that threatens DE SIMONE FORMULATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.